- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Maple Leaf Green World Inc. Engages Emerging Equity Inc. to Raise $20 Million Private Placement
Maple Leaf Green World (OTCQB:MGWFF) is pleased to announce that it has entered into an engagement letter with Emerging Equities Inc. (“EEI”) with respect to a proposed brokered private placement financing for gross proceeds of a minimum of $1,000,000 and a maximum of $20,000,000 (the “Offering”).
Maple Leaf Green World (OTCQB:MGWFF) is pleased to announce that it has entered into an engagement letter with Emerging Equities Inc. (“EEI”) with respect to a proposed brokered private placement financing for gross proceeds of a minimum of $1,000,000 and a maximum of $20,000,000 (the “Offering”). The Offering will consist of units of the Company (the “Units”) at an offering price of $0.65 per Unit. Each Unit will be comprised of one common share in the capital of the Company (each, a “Common Share”) and one Common Share purchase warrant (each, a “Warrant”). Each whole Warrant will entitle the holder to acquire one Common Share at an exercise price of $1.00 up until and including May 1, 2020.
EEI is an active participant in funding and providing strategic and financial advice to Canadian based cannabis companies and will act as agent for the Offering, which will be conducted on a commercially reasonable best efforts basis. As compensation for its services, EEI will be entitled to an agent’s commission in an amount equal to 7% of the gross proceeds of the Offering (the “Agent’s Commission”). Notwithstanding the foregoing, no Agent’s Commission will be payable for the first $2,000,000 of subscriptions to the Offering made by certain subscribers on a president’s list provided by the Company to EEI (the “President’s List Subscribers”). As additional compensation, EEI will also be issued options (the “Agent’s Option’s”) equal to 7% of the number of Units sold under the Offering, Each Agent’s Option will be exercisable for a Common Share at an exercise price of $0.65, for a period of twenty-four (24) months from the closing of the Offering.
Closing of the Offering is targeted to occur on May 31, 2018, or such other date as may be mutually agreed upon between EEI and the Company.
The Company intends to use the first $10,000,000 of the net proceeds of the Offering, as applicable, to advance its engineering and construction plans for its cannabis cultivation facilities in Telkwa, British Columbia and Henderson, Nevada. Any additional proceeds from the Offering will be used for the expansion plans of the Company and for general corporate purposes.
For further information regarding the Company, please visit www.mlgreenworld.com.
About Maple Leaf Green World Inc.
Maple Leaf is a public Canadian company that focuses on the cannabis industry in North America. The Company currently operates cannabis projects in British Columbia and Nevada. With over ten years of extensive greenhouse management experience, the Company applies its eco-agriculture knowledge and cultivation technology to produce contaminant-free organic cannabis products. Maple Leaf’s long-term objective is to produce cannabis oil and to export its products to approved countries. The Company’s common shares are listed for trading on the Aequitas NEO Exchange Inc. (the “NEO Exchange”) under the symbol “MGW” and on the OTCQB market under the symbol “MGWFF”.
Cautionary Statements
This press release includes certain statements and information that may be deemed “forward-looking statements” within the meaning of applicable Canadian securities legislation. Such forward-looking information relates to future events about Maple Leaf’s intended business plans and operations. All information other than historical fact may constitute forward-looking information within the meaning of applicable Canadian securities legislation.
Generally, forward-looking information can be identified by the forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget” or “budgeted”, “scheduled”, “estimates”, “projects”, “intends”, “proposes”, “complete”, “anticipates”, or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “can”, “could”, “would”, “might”, or “will be taken”, “occur”, or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties, and other factors that may cause the actual results, level of activity, performance, or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to: risks related to the development and operation of the Company’s projects, risks associated with general economic conditions, adverse industry events, marketing costs, loss of markets, future legislative and regulatory developments involving medical cannabis, inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms, the medical cannabis industry in Canada and the jurisdictions where the Company operates generally, income and sales tax and regulatory matters, competition, crop failure, currency and interest rate fluctuations, regulatory approvals including approvals from municipal, provincial, county, state, and federal regulatory bodies in Canada. Although the Company has attempted to identify important factors that could cause results to differ materially from those contained in forward-looking information, there may be other factors that cause results to be materially different from those anticipated, described, estimated, assessed, planned, or intended. Accordingly, such list of factors are not exhaustive. Additional information on these and other factors which could affect the Company’s operations and financial results are discussed in the sections relating to risk factors of the business filed in the Company’s required securities filings with applicable securities commissions or other securities regulatory authorities and which may be accessed through the SEDAR website ( www.sedar.com ).
Specifically, this press release includes, but is not limited to, forward-looking information with respect to the timing and completion of the Offering, the use of net proceeds from the Offering, the receipt of regulatory approvals, and the timing thereof, the future operations of the Company, and other statements that are not historical facts. These forward-looking statements are made as of the date of this press release and the Company does not undertake to update any forward-looking information contained in this press release or that is incorporated by reference herein, whether as a result of new information, future events or results or otherwise, except in accordance with applicable securities laws.
Source: www.nasdaq.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.